Anaptysbio

Anaptysbio

ANAB· Manufacturing· Fiscal year ends in June

CEO pay in FY2025Stock -11.4% in FY2025

Daniel Faga is the CEO of Anaptysbio and was paid $6.1M in FY2025 (Jun), down 55%.

Pay$100 in the stock at the end of FY21 → $86
CEO pay is from each Anaptysbio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Daniel FagaFY2025
  2. 2Paul LizzulFY2025
  3. 3Dennis MulroyFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Anaptysbio paid its 3 named executives $10.5M in total in FY2025 (Jun). CEO Daniel Faga was paid $6.1M of that.

Name
Daniel FagaPresident and Chief Executive Officer and Director
Paul LizzulChief Medical Officer
Dennis MulroyChief Financial Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers15

See all

The FY2025 (Jun) proxy of Anaptysbio names 15 peer companies for pay. Among Anaptysbio and these peers, CEO pay was 2nd highest of 3 and total shareholder return was the highest of 3.

2nd highest of 3in Anaptysbio and its pay peers, FY2025 (Jun) by CEO pay:

$4.7M$8.5M

1st highest of 3in Anaptysbio and its pay peers, FY2025 (Jun) by total shareholder return:

$84$156

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Oleg NodelmanDirector · 4 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A

Filings3

See all
Proxy statementDEF 14AJun 29, 2026FY2025
Proxy statementDEF 14AApr 29, 2025FY2024
Proxy statementDEF 14AApr 24, 2024FY2023